Invesaro

Stocks GWTI Financial statements

Financial statements

GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Research and development0.970.870.630.440.030.160.050.051.21
General and administrative1.058.262.261.991.340.960.890.960.842.49
Operating expenses2.029.132.892.431.371.120.940.960.893.69
Operating income-2.02-9.13-2.89-2.43-1.37-1.12-0.94-0.96-0.89-3.69
Interest expense-0.010.440.770.590.620.61
Other non-operating income-0-0.02-0.31-1.23-1.17-0.62-0.57-0.62-0.621.74
Pre-tax income-2.02-9.15-3.19-3.66-2.54-1.74
Income tax0000
Net income-2.02-9.15-3.19-3.66-2.54-1.74-1.51-1.58-1.51-1.96
EBITDA-2.02-9.13-2.89-2.43-1.37-1.12
EPS, basic-0.01-0.03-0.01-0.01-0.01-0.010.000.000.000.00
EPS, diluted-0.01-0.03-0.01-0.01-0.01-0.010.000.000.000.00
Shares, basic (weighted)202273286292313342372398413445
Shares, diluted (weighted)202273286292313342372398413445

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents0.070.090.070.0200.060.0200.020
Other current assets0.160.030.010000.05
Total current assets0.080.250.070.430.010.060.0300.020.05
Property, plant and equipment0000
Intangible assets0
Total assets0.090.270.090.430.010.060.0300.020.05
Accounts payable0.090.140.740.770.810.673.32
Accrued liabilities0.250.780.730.640.861.13
Total current liabilities2.534.786.798.869.9510.8121314.1
Long-term debt0.53
Total liabilities2.53.084.787.328.869.9510.8121314.1
Paid-in capital1220.822.122.724.124.825.525.826.327.2
Retained earnings-14.5-23.6-26.8-30.5-33-34.8-36.3-37.9-39.4-41.3
Shareholders' equity-2.42-2.81-4.69-6.89-8.84-9.89-10.7-12-13-14.1
Total equity-2.42-2.81-4.69-6.89-8.84-9.89-10.7-12-13-14.1
Total liabilities and equity0.090.270.090.430.010.060.0300.020.05
Shares outstanding0.13287297335355383404431456

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-2.02-9.15-3.19-3.66-2.54-1.74-1.51-1.58-1.51-1.96
Depreciation and amortization000000
Stock-based compensation0.045.650.050.420.040.010.01
Deferred income tax000
Change in payables00.210.780.29-00.160.330.510.341.55
Cash from operations-1.85-2.23-1.29-1.3-0.69-0.79-0.5-0.3-0.44-0.71
Cash from investing00-0.39-0.03
Debt repaid-0.1
Stock issued1.762.190.60.360.160.660.480.270.460.7
Share buybacks0-0.07
Cash from financing1.912.251.271.630.70.850.460.280.460.69
Net change in cash0.07-0.02-0.06-0.010.06-0.04-0.020.02-0.02
Interest paid0.01000.050.050.040.050.28
Income taxes paid00

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $0.01 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Return on assets (ROA)-3,344.0%Net income / average total assets.

Growth

MetricValueHow it is calculated
Total assets growth, 1y130.9%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y19.3%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y29.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y7.7%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y6.2%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y7.3%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.00xCurrent assets / current liabilities.
Quick ratio0.00x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.00x(Cash + short-term investments) / current liabilities.
Liabilities / assets28,263.0%Total liabilities / total assets.
Working capital-$14.5MCurrent assets - current liabilities.
Tangible book value-$14.5MShareholders' equity - goodwill - intangible assets.

Per share

MetricValueHow it is calculated
EPS, diluted-$0.00Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Operating cash flow per share-$0.00Cash from operations / diluted weighted shares.
Book value per share-$0.03Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$0.03Tangible book value / shares outstanding.
Cash per share$0.00(Cash + short-term investments) / shares outstanding.

Valuation

MetricValueHow it is calculated
Market cap$6.2MShare price x shares outstanding.
Enterprise value$6.2MMarket cap + total debt - cash - short-term investments.
Earnings yield-27.5%Net income / market cap (the inverse of P/E).
Was GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES profitable in fiscal 2025?

No. It reported a net loss of $2.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to GREENWAY TECHNOLOGIES, INC. & SUBSIDIARIES